Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Antimicrobial Resistance & Infection Control
Published in: Antimicrobial Resistance & Infection Control 1/2017

Open Access 01-12-2017 | Research

Urinary pathogenic bacterial profile, antibiogram of isolates and associated risk factors among pregnant women in Ambo town, Central Ethiopia: a cross-sectional study

Authors: Yonas Alem Gessese, Dereje Leta Damessa, Mebratenesh Mengistu Amare, Yonas Hailesilassie Bahta, Assalif Demisew Shifera, Fikreslasie Samuel Tasew, Endrias Zewdu Gebremedhin

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2017

Login to get access

Abstract

Background

Urinary tract infection (UTI) is a well-known bacterial infection posing serious health problem in pregnant women. A study was conducted in pregnant women with the objectives of estimating prevalence of UTI, determining antibiogram of the bacterial isolates and assessment of the potential risk factors associated with UTI.

Methods

A cross-sectional study design was used to collect 300 mid-stream urine samples from pregnant women from March 2016 to December, 2016. Samples were inoculated into Cysteine Lactose Electrolyte Deficient medium (CLED). Colonies from CLED were subcultured onto MacConkey and Blood agar plates. A standard agar disc diffusion method was used to determine antimicrobial susceptibility. Chi-square (X 2 ) test & logistic regression were used to show associations between UTI and explanatory variables & identify the predictors of UTI, respectively.

Results

The age of pregnant women enrolled in this study ranges from 16 to 46 years (mean ± standard deviation = 25 ± 4.7 years).The overall prevalence of UTI in pregnant women was 18.7% (95% confidence interval [CI]: 14.4–23.54%).The prevalence of symptomatic and asymptomatic UTI was 20.4% (95% CI: 13.09–29.46%) and 17.8% (95% CI: 12.70–23.83%) respectively. The predominant bacteria identified were E. coli (46.4%), S. aureus (14.3%), coagulase negative Staphylococci [CoNS] (14.3%) and Proteus species (10.6%). Majority of Gram-negative bacteria isolates were resistant to ampicillin (70%), ceftriaxon (66%), gentamicin (68%) and nitrofurantoin (64%) while 75–100% of the Gram positive isolates were resistance to ampicillin. Multiple drug resistance was observed in all of the isolates. Multivariable logistic regression revealed that the odds of acquiring UTI was 4.78 times higher in pregnant women earning monthly income of ≤500 Ethiopian Birr (21.18 USD) as compared to those earning monthly income >2001 Ethiopian Birr [84.79 USD] (P = 0.046). Similarly, the risk of UTI was higher in those who eat raw meat (OR = 2.04, 95% CI: 1.09, 3.83, P = 0.026) and had previous UTI history (OR = 2.29, 95% CI = 1.15–4.56, P = 0.019) as compared to those who eat cooked meat and had no previous history of UTI.

Conclusions

The prevalence & antimicrobial resistance of uropathogens was high. Health education, continuous surveillance of UTI and their antimicrobial resistance pattern are essential to reduce the consequence of symptomatic and asymptomatic bacteriuria and multi-drug resistant bacteria in pregnant women.
Literature
1.
Alemu A, Moges F, Shiferaw Y, Tafesse K, Kassu A, Anagaw B, Agegn A. Bacterial profile and drug susceptibility pattern of UTI in pregnant women at University of Gondar teaching hospital. Ethiop J Health Sci. 2012;25(5):197. doi: 10.​1186/​1756-0500-5-197.​
2.
3.
Tazebew D, Getenet B, Selabat M, Wondewosen T. Urinary bacterial profile and antibiotic susceptibility pattern among pregnant women in north West Ethiopia. Ethiop J of Health Sci. 2012;22(2):121–8.
4.
Mittal P, Wing DA: Urinary tract infections in pregnancy. Clin Perinatol 2005, 32:749-7641. PubMed Abstract | Publisher Full Text.
5.
Alfred AO, Chiedozie I, Martin DU. Pattern of asymptomatic bacteriuria among pregnant women attending an antenatal clinic at a private health facility in Benin, South Nigeria. Ann Afr Med. 2013;12(3):160–4.CrossRefPubMed
6.
Dash M, Sahu S, Mohanty I, Narasimham MV, Turuk J, Sahu R. Prevalence, risk factors and antimicrobial resistance of asymptomatic bacteriuria among antenatal women. Basic ClinReprodSci. 2013;2(2):92–6.
7.
8.
Connolly A, Thorp J. Urologic clinic of North America. 1999;26:776–87.
9.
Ade-Ojo IP, Oluyege AO, Adegun PT, Akintayo AA, Aduloju OP, Olofinbiyi BA. Prevalence and antimicrobial susceptibility of asymptomatic significant bacteriuria among new antenatal enrollees in Southwest Nigeria. Intl Res J Microbiol. 2013;4(8):197–203.
10.
Fred NW, Gichuhi JW, Mugo NW. Prevalence of UTI, microbial etiology, and antibiotic sensitivity pattern among antenatal women presenting with lower abdominal pains at Kenyatta National Hospital, Nairobi, Kenya. J Sci and Tech. 2015;3(6) doi: 10.​11131/​2015/​101115.
11.
Matuszkiewicz-Rowinska J, Małyszko J, Wieliczko M. Urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems. Archives of Med Sci. 2015;11(1):67–77.CrossRef
12.
Kabew G, Abebe T, Miheret A. A retrospective study on prevalence and antimicrobial susceptibility patterns of bacterial isolates from urinary tract infections in Tikur Anbessa specialize teaching hospital, Addis Ababa, Ethiopia. Ethiop J Health Devel. 2011;27(2):112–7.
13.
Beyene G, Tsegaye W. Bacterial Uropathogens in UTI and antibiotic susceptibility pattern in Jimma University specialized hospital. Ethiop J Health Sci. 2011;21(2):141–6.CrossRefPubMedPubMedCentral
14.
DACA (2009). Antimicrobials use, resistance and containment baseline survey syntheses of findings, august 2009, Addis Ababa, Ethiopia.
15.
Haider G, Zehra N, Munir A, Haider A. Risk factors of UTI in pregnancy. J Pak Med Assoc. 2010;60(3):213–6.PubMed
16.
Ezechi OC, Gab-Okafor CV, Oladele DA, Kalejaiye OO, Oke BO, Ekama SO, Audu RA, Okoye RN, Ujah IA. Prevalence and risk factors of asymptomatic bacteriuria among pregnant Nigerians infected with HIV. J Matern Fetal Neonatal Med. 2013;26(4):402–6.CrossRefPubMed
17.
Israel GD. Sampling the evidence of extension program impact. Program evaluation and organizational development, IFAS. University of Florida: PEOD-5; 1992.
18.
Assefa A., Asrat D., Woldeamanuel Y., G/Hiwot Y., Abdella A., and Melesse T. (2008). Bacterial profile and drug susceptibility pattern of UTI in pregnant women at Tikur Anbessa specialized hospital. Ethiop Med J, 46 (3), 227-235.
19.
Maji SK, Maity C, Halder SK, Paul T, Kundu PK, Mondal KC. Studies on drug sensitivity and bacterial prevalence of UTI in tribal population of PaschimMedinipur, West Bengal, India. Jundishapur J Microbiol. 2012;6(1):42–6.CrossRef
20.
21.
Rizvi M., Khan F., Shukla I., Malik A. and Shaheen (2011). Rising prevalence of antimicrobial resistance in urinary tract infections during pregnancy: necessity for exploring newer treatment options. J Lab Physicians, 3 (2), 98-103.
22.
Mgbakogu RA, Eledo BO. Polymicrobial agents and antibiotic profile of urinary tract infections among pregnant women in Anambra state, Nigeria. Advances in Life Sci and Tech. 2015;35(38):224–36.
23.
National Committee for Clinical Laboratory Standards (Clinical Laboratory Standard Instituetes). (2012). Performance of standard for antimicrobial disk susceptibility tests: approved standards. M2-A7. PA, USA: NCCL, 32 (1), Villanova.
24.
25.
Shaifali I, Gupta U, Mahmood SE, Ahmed J. Antibiotic susceptibility patterns of urinary pathogens in female outpatients. North Am J Med Sci. 2012;4(4):163–9.CrossRef
26.
Hamdan ZH, Ziad AM, Ali SK, Adam I. Investigating epidemiology of UTI and antibiotics sensitivity among pregnant women Khartoum hospital. Ann ClinMicrobiol and Antimicrobials. 2011;10(2) doi: 10.​1186/​1476-0711-10-2.
27.
Masinde A, Gumodoka B, Kilonzo A, Mshana SE. Prevalence of urinary tract infection among pregnant women at Bugando medical Centre, Mwanza, Tanzania. Tanzan J Health Res. 2009;11(3):154–9.PubMed
28.
Derese B, Kedir H, Teklemariam Z, Weldegebreal F, Balakrishnan S. Bacterial profile of UTI and antimicrobial susceptibility pattern among pregnant women attending at antenatal Clinic in Dil Chora Referral Hospital, Dire Dawa, eastern Ethiopia. TherClin Risk Manag. 2016;12(1):251–60.
29.
30.
Hisano M, Bruschini H, Nicodemo AC, Gomes CM, Lucon M, Srougi M. The bacterial spectrum and antimicrobial susceptibility in female recurrent UTI. Urology. 2015;86(3):492–7.CrossRefPubMed
31.
Lavigne JP, Boutet-Dubois A, Laouini D, Combescure C, Bouziges N, Mares P, andSotto A. Virulence potential of E. coli strains causing asymptomatic bacteriuria during pregnancy. J ClinMicrobiol, 2011. 2011;49(11):3950–3.
32.
Mandira M, Snehashis K, SandipKumar M, Shreya B, Biplab G, Somajita C. Phylogenetic background of E. coli isolated from asymptomatic pregnant women from Kolkata, India. J Infect Devel Countries. 2015;9(7):720–4.CrossRef
33.
Ramos NL, Sekikubo M, Dzung DT, Kosnopfel C, Kironde F, Mirembe F, Brauner A. Uropathogenic E. coli isolates from pregnant women in different countries. J ClinMicrobiol. 2012;50(11):3569–74.
34.
NM Gilbert, VP O’Brien, S Hultgren, G Macones, WG Lewis, AL Lewis (2013). Urinary tract infection as a preventable cause of pregnancy complications: opportunities, challenges, and a global call to action. Global Adv Health Med. 2013;2(5):59-69. DOI: 10.​7453/​gahmj.​2013.​061.
35.
Forsyth DM, Bradley DJ. The consequences of bilharziasis; medical and public health importance in north-west Tanzania. Bull WHO. 1966;34:715–35.PubMedPubMedCentral
36.
Onanuga A, Selekere TL. Virulence and antimicrobial resistance of common urinary bacteria from asymptomatic students of Niger Delta University, Amassoma, Bayelsa state, Nigeria. J Pharm and Bioallsci. 2016;8(1):29–33.CrossRef
37.
Rasamiravaka T, Shaistasheila HS, Rakotomavojaona T, Rakoto-Alson AO, andRasamindrakotroka A. Changing profile & increasing antimicrobial resistance of uropathogenic bacteria in Madagascar. Med Mal Infect. 2015;45(5):173–6.CrossRefPubMed
38.
Onanuga A, Awhowho GO. Antimicrobial resistance of Staphylococcus aureus strains from patients with urinary tract infections in Yenagoa, Nigeria. J Pharm and Bioallsci. 2012;4(3):226–30.CrossRef
39.
Gebrekirstos NH, Workneh BD, Gebregiorgis YS, Misgina KH, Weldehaweria NB, Weldu MG, Belay HS. Non-prescribed antimicrobial use and associated factors among customers in drug retail outlet in central zone of Tigray, northern Ethiopia: a cross-sectional study. 2017;6:70. doi: 10.​1186/​s13756-017-0227-7.
40.
Getachew K, Tamirat A, Adane M. A retrospective study on prevalence and antimicrobial susceptibility patterns of bacterial isolates from UTIs in Tikur Anbessa specialize teaching hospital, Addis Ababa, Ethiopia. Ethiop J of Health Devel. 2013;27(2):111–7.
41.
Demilie T, Beyene G, Melaku S, Tsegaye W. Diagnostic accuracy of rapid urine dipstick test to predict UTI among pregnant women in Felege Hiwot referral hospital, Bahir Dar, Ethiopia. BMC Res Notes. 2014;29(7):481. doi: 10.​1186/​1756-0500-7-481.​
42.
Al-Badr A, Al-Shaikh G. Recurrent UTIs Management in Women. Sultan Qaboos Universal Med J. 2013;13(3):359–67.CrossRef
43.
Vincent C, Boerlin P, Daignault D, Dozois CM, Dutil L, Galanakis C, Reid-Smith RJ, Tellier P, Tellis PA, Ziebell K, Manges AR. Food reservoir for E. coli causing UTIs. Emerg Infect Dis. 2010;16(1):88–95.CrossRefPubMedPubMedCentral
44.
Nordstrom L, Liu Cindy M, Lance B, Price LB. Foodborne urinary tract infections: a new paradigm for antimicrobial-resistant foodborne illness. J. Front Microbiol. 2013;4(29) doi: 10.​3389/​fmicb.​2013.​00029.
45.
Gizachew Y, Daniel A, Yimtubezinash W, Chandrashekhar GU. Urinary tract infection, bacterial etiologies, drug resistance profile and associated risk factors in diabetic patients attending Gondar University hospital, Gondar, Ethiopia. Europ J ExperBiol. 2012;2(4):889–98.
46.
Mucheye G, Mulugeta K, Yared M, Yenework S, Moges T, Martha A. E. coli isolated from patients suspected for urinary tract infections in Hawassa referral hospital, southern Ethiopia, an institution based cross sectional study. J. Microbiol Res. 2013;1(1):009–15.
Metadata
Title
Urinary pathogenic bacterial profile, antibiogram of isolates and associated risk factors among pregnant women in Ambo town, Central Ethiopia: a cross-sectional study
Authors
Yonas Alem Gessese
Dereje Leta Damessa
Mebratenesh Mengistu Amare
Yonas Hailesilassie Bahta
Assalif Demisew Shifera
Fikreslasie Samuel Tasew
Endrias Zewdu Gebremedhin
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2017
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-017-0289-6

Other articles of this Issue 1/2017

Antimicrobial Resistance & Infection Control 1/2017 Go to the issue

Review

How externalities impact an evaluation of strategies to prevent antimicrobial resistance in health care organizations

Research

Ralstonia mannitolilytica infections in an oncologic day ward: description of a cluster among high-risk patients

Research

Shiga (Vero)-toxin producing Escherichia coli isolated from the hospital foods; virulence factors, o-serogroups and antimicrobial resistance properties

Research

Antibiotic resistance and biofilm formation among coagulase-negative staphylococci isolated from clinical samples at a tertiary care hospital of eastern Nepal

Research

Risk factors for Clostridium difficile infection in surgical patients hospitalized in a tertiary hospital in Belgrade, Serbia: a case–control study

Research

Non-prescribed antimicrobial use and associated factors among customers in drug retail outlet in Central Zone of Tigray, northern Ethiopia: a cross-sectional study

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits